6,688
Views
22
CrossRef citations to date
0
Altmetric
Review

Paracetamol and morphine for infant and neonatal pain; still a long way to go?

, , , , , & show all
Pages 111-126 | Received 14 Jun 2016, Accepted 25 Oct 2016, Published online: 09 Nov 2016

References

  • Krekels, E.H., Tibboel, D., De Wildt, S. N, et al., Evidence-based morphine dosing for postoperative neonates and infants. Clin Pharmacokinet, 2014. 53(6): p. 553–563.
  • Knibbe CA, Krekels EHJ, Van Den Anker JN, et al. Morphine glucuronidation in preterm neonates, infants and children younger than 3 years. Clin Pharmacokinet. 2009;48(6):371–385.
  • Ceelie I, De Wildt SN, Van Dijk M, et al. Effect of intravenous paracetamol on postoperative morphine requirements in neonates and infants undergoing major noncardiac surgery: a randomized controlled trial. Jama. 2013;309(2):149–154.
  • Wang C, Allegaert K, Tibboel D, et al. Population pharmacokinetics of paracetamol across the human age-range from (pre)term neonates, infants, children to adults. J Clin Pharmacol. 2014;54(6):619–629.
  • Anand KJ, Craig KD. New perspectives on the definition of pain. Pain. 1996;67(1):3-6; discussion 209-11.
  • Loeser JD. Pain and suffering. Clin J Pain. 2000;16(2):S2–S6.
  • Cassel EJ. The nature of suffering and the goals of medicine. N Engl J Med. 1982;306(11):639–645.
  • Pillai Riddell RR, Stevens BJ, McKeever P, et al. Chronic pain in hospitalized infants: health professionals’ perspectives. J Pain. 2009;10(12):1217–1225.
  • Harris J, Ramelet AS, Van Dijk M, et al. Clinical recommendations for pain, sedation, withdrawal and delirium assessment in critically ill infants and children: an ESPNIC position statement for healthcare professionals. Intensive Care Med. 2016;42(6):972–986.
  • Harstall C, Ospina M. How prevalent is chronic pain? Pain Clinical Updates. 2003;11(2):1–4.
  • Van Dijk M, Tibboel D. Update on pain assessment in sick neonates and infants. Pediatr Clin North Am. 2012;59(5):1167–1181.
  • Committee On Fetus and. Newborn and section on anesthesiology and pain medicine, prevention and management of procedural pain in the neonate: an update. Pediatrics. 2016;137(2):1–13.
  • McGrath PJ, Walco GA, Turk DC, et al. Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: pedIMMPACT recommendations. J Pain. 2008;9(9):771–783.
  • Jonsdottir RB, Kristjansdottir G. The sensitivity of the premature infant pain profile - PIPP to measure pain in hospitalized neonates. J Eval Clin Pract. 2005;11(6):598–605.
  • Ballantyne M, Stevens B, McAllister M, et al. Validation of the premature infant pain profile in the clinical setting. Clin J Pain. 1999;15(4):297–303.
  • McNair C, Ballantyne M, Dionne K, et al. Postoperative pain assessment in the neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed. 2004;89(6):F537–F41.
  • Stevens BJ, Gibbins S, Yamada J, et al. The premature infant pain profile-revised (PIPP-R): initial validation and feasibility. Clin J Pain. 2014;30(3):238–243.
  • Gibbins S, Stevens BJ, Yamada J, et al. Validation of the Premature Infant Pain Profile-Revised (PIPP-R). Early Hum Dev. 2014;90(4):189–193.
  • Hummel P, Lawlor-Klean P, Weiss MG. Validity and reliability of the N-PASS assessment tool with acute pain. J Perinatol. 2010;30(7):474–478.
  • Van Dijk M, Roofthooft DWE, Anand KJS, et al. Taking up the challenge of measuring prolonged pain in (premature) neonates: the COMFORTneo scale seems promising. Clin J Pain. 2009;25(7):607–616.
  • Van Dijk M, De Boer JB, Koot HM, et al. The reliability and validity of the COMFORT scale as a postoperative pain instrument in 0 to 3-year-old infants. Pain. 2000;84(2–3):367–377.
  • Ambuel B, Hamlett KW, Marx CM, et al. Assessing distress in pediatric intensive care environments: the COMFORT scale. J Pediatr Psychol. 1992;17(1):95–109.
  • Van Dijk M, De Boer JB, Koot HM, et al. The association between physiological and behavioral pain measures in 0- to 3-year-old infants after major surgery. J Pain Symptom Manage. 2001;22(1):600–609.
  • Merkel SI, Voepel-Lewis T, Shayevitz JR, et al. The FLACC: a behavioral scale for scoring postoperative pain in young children. Pediatr Nurs. 1997;23(3):293–297.
  • Crellin DJ, Harrison D, Santamaria N, et al. Systematic review of the face, legs, activity, cry and consolability scale for assessing pain in infants and children: is it reliable, valid, and feasible for use? Pain. 2015;156(11):2132–2151.
  • Ramelet AS, Rees NW, McDonald S, et al. Clinical validation of the multidimensional assessment of pain scale. Paediatr Anaesth. 2007;17(12):1156–1165.
  • Slater R, Cantarella A, Franck L, et al. How well do clinical pain assessment tools reflect pain in infants? PLoS Med. 2008;5(6):e129.
  • Olsson E, Ahlsen G, Eriksson M. Skin-to-skin contact reduces near-infrared spectroscopy pain responses in premature infants during blood sampling. Acta Paediatr. 2016;105(4):376–380.
  • Davidson AJ. Monitoring the anaesthetic depth in children - an update. Curr Opin Anaesthesiol. 2007;20(3):236–243.
  • Solana MJ, Lopez-Herce J, Fernandez S, et al. Assessment of pain in critically ill children. Is cutaneous conductance a reliable tool? J Crit Care. 2015;30(3):481–485.
  • Valkenburg AJ, Niehof SP, Van Dijk M, et al. Skin conductance peaks could result from changes in vital parameters unrelated to pain. Pediatr Res. 2012;71(4 Pt 1):375–379.
  • Harrison D, Boyce S, Loughnan P, et al. Skin conductance as a measure of pain and stress in hospitalised infants. Early Hum Dev. 2006;82(9):603–608.
  • Hullett B, Chambers N, Preuss J, et al. Monitoring electrical skin conductance: a tool for the assessment of postoperative pain in children? Anesthesiology. 2009;111(3):513–517.
  • Lamas A, López-Herce J, Sancho L, et al. Assessing sedation in critically ill children by bispectral index, auditory-evoked potentials and clinical scales. Intensive Care Med. 2008;34(11):2092–2099.
  • Slater R, Cornelissen L, Fabrizi L, et al. Oral sucrose as an analgesic drug for procedural pain in newborn infants: a randomised controlled trial. Lancet. 2010;376(9748):1225–1232.
  • Connelly MA, Brown JT, Kearns GL, et al. Pupillometry: a non-invasive technique for pain assessment in paediatric patients. Arch Dis Child. 2014;99(12):1125–1131.
  • Constant I, Nghe M-C, Boudet L, et al. Reflex pupillary dilatation in response to skin incision and alfentanil in children anaesthetized with sevoflurane: a more sensitive measure of noxious stimulation than the commonly used variables. Br J Anaesth. 2006;96(5):614–619.
  • Gall O, Champigneulle B, Schweitzer B, et al. Postoperative pain assessment in children: a pilot study of the usefulness of the analgesia nociception index. Br J Anaesth. 2015;115(6):890–895.
  • Avez-Couturier J, De Jonckheere J, Jeanne M, et al. Assessment of procedural pain in children using analgesia nociception index: a pilot study. Clin J Pain. 2016. [Epub ahead of print].
  • Lindh V, Wiklund U, Sandman PO, et al. Assessment of acute pain in preterm infants by evaluation of facial expression and frequency domain analysis of heart rate variability. Early Hum Dev. 1997;48(1–2):131–142.
  • Evans S, Seidman LC, Tsao JC, et al. Heart rate variability as a biomarker for autonomic nervous system response differences between children with chronic pain and healthy control children. J Pain Res. 2013;6:449–457.
  • Jeanne M, Logier R, De Jonckheere J, et al. Heart rate variability during total intravenous anesthesia: effects of nociception and analgesia. Auton Neurosci. 2009;147(1–2):91–96.
  • Faye PM, De Jonckheere J, Logier R, et al. Newborn infant pain assessment using heart rate variability analysis. Clin J Pain. 2010;26(9):777–782.
  • Sabourdin N, Arnaout M, Louvet N, et al. Pain monitoring in anesthetized children: first assessment of skin conductance and analgesia-nociception index at different infusion rates of remifentanil. Paediatr Anaesth. 2013;23(2):149–155.
  • Migeon A, Desgranges F-P, Chassard D, et al. Pupillary reflex dilatation and analgesia nociception index monitoring to assess the effectiveness of regional anesthesia in children anesthetised with sevoflurane. Paediatr Anaesth. 2013;23(12):1160–1165.
  • Padhye NS, Williams AL, Khattak AZ, et al. Heart rate variability in response to pain stimulus in VLBW infants followed longitudinally during NICU stay. Dev Psychobiol. 2009;51(8):638–649.
  • Boselli E, Jeanne M. Analgesia/nociception index for the assessment of acute postoperative pain. Br J Anaesth. 2014;112(5):936–937.
  • Ledowski T. Analgesia-nociception index. Br J Anaesth. 2014;112(5):937.
  • Jess G, Pogatzki-Zahn EM, Zahn PK, et al. Monitoring heart rate variability to assess experimentally induced pain using the analgesia nociception index: A randomised volunteer study. Eur J Anaesthesiol. 2016;33(2):118–125.
  • Broucqsault-Dedrie C, De Jonckheere J, Jeanne M, et al. Measurement of heart rate variability to assess pain in sedated critically ill patients: a prospective observational study. PLoS One. 2016;11(1):e0147720.
  • Goksan, S., Hartley, C., Emery, F, et al. fMRI reveals neural activity overlap between adult and infant pain. elife. 2015;4:e06356.
  • Williams G, Fabrizi L, Meek J, et al. Functional magnetic resonance imaging can be used to explore tactile and nociceptive processing in the infant brain. Acta Paediatr. 2015;104(2):158–166.
  • Anand KJ, Sippell WG, Aynsley-Green A. Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response. Lancet. 1987;1(8527):243–248.
  • Franck LS, Ridout D, Howard R, et al. A comparison of pain measures in newborn infants after cardiac surgery. Pain. 2011;152(8):1758–1765.
  • Rohan AJ. Pain-associated stressor exposure and neuroendocrine values for premature infants in neonatal intensive care. Dev Psychobiol. 2016;58(1):60–70.
  • Simons SH, Van Dijk M, Van Lingen RA, et al. Randomised controlled trial evaluating effects of morphine on plasma adrenaline/noradrenaline concentrations in newborns. Arch Dis Child Fetal Neonatal Ed. 2005;90(1):F36–F40.
  • Ranger M, Celeste Johnston C, Rennick JE, et al. A multidimensional approach to pain assessment in critically ill infants during a painful procedure. Clin J Pain. 2013;29(7):613–620.
  • Young Infants Clinical Signs Study, G. Clinical signs that predict severe illness in children under age 2 months: a multicentre study. Lancet. 2008;371(9607):135–142.
  • McKeever S, Johnston L, Davidson AJ. An observational study exploring amplitude-integrated electroencephalogram and spectral edge frequency during paediatric anaesthesia. Anaesth Intensive Care. 2012;40(2):275–284.
  • Olischar M, Shany E, Aygün C, et al. Amplitude-integrated electroencephalography in newborns with inborn errors of metabolism. Neonatology. 2012;102(3):203–211.
  • Kasdorf E, Engel M, Perlman JM. Amplitude electroencephalogram characterization in preterm infants undergoing patent ductus arteriosus ligation. Pediatr Neurol. 2013;49(2):102–106.
  • Worley A, Fabrizi L, Boyd S, et al. Multi-modal pain measurements in infants. J Neurosci Methods. 2012;205(2):252–257.
  • Valitalo PA, Van Dijk M, Krekels EHJ, et al. Pain and distress caused by endotracheal suctioning in neonates is better quantified by behavioural than physiological items: A comparison based on item response theory modelling. Pain. 2016;157:1611–1617.
  • Pillai Riddell R, Fitzgerald M, Slater R, et al. Using only behaviours to assess infant pain: a painful compromise? Pain. 2016;157(8):1579–1580.
  • Berde C, McGrath P. Pain measurement and Beecher’s challenge: 50 years later. Anesthesiology. 2009;111(3):473–474.
  • Beecher HK. Measurement of subjective responses. Quantitative effects of drugs. New York, NY: Oxford University Press; 1959. p. 57–98.
  • Anand KJ, Sippell WG, Schofield NM, et al. Does halothane anaesthesia decrease the metabolic and endocrine stress responses of newborn infants undergoing operation? Br Med J (Clin Res Ed). 1988;296(6623):668–672.
  • Quinn MW, Otoo F, Rushforth JA, et al. Effect of morphine and pancuronium on the stress response in ventilated preterm infants. Early Hum Dev. 1992;30(3):241–248.
  • Pokela ML, Olkkola KT, Seppälä T, et al. Age-related morphine kinetics in infants. Dev Pharmacol Ther. 1993;20(1–2):26–34.
  • Beyer JE, DeGood DE, Ashley LC, et al. Patterns of postoperative analgesic use with adults and children following cardiac surgery. Pain. 1983;17(1):71–81.
  • Caes L, Boerner KE, Chambers CT, et al. A comprehensive categorical and bibliometric analysis of published research articles on pediatric pain from 1975 to 2010. Pain. 2016;157(2):302–313.
  • Van Dijk M, Bouwmeester NJ, Duivenvoorden HJ, et al. Efficacy of continuous versus intermittent morphine administration after major surgery in 0-3-year-old infants; a double-blind randomized controlled trial. Pain. 2002;98(3):305–313.
  • Van Der Marel CD, Peters JWB, Bouwmeester NJ, et al. Rectal acetaminophen does not reduce morphine consumption after major surgery in young infants. Br J Anaesth. 2007;98(3):372–379.
  • Simons SH, Van Dijk M, Van Lingen RA, et al. Routine morphine infusion in preterm newborns who received ventilatory support: a randomized controlled trial. Jama. 2003;290(18):2419–2427.
  • Barker DP, Simpson J, Pawula M, et al. Randomised, double blind trial of two loading dose regimens of diamorphine in ventilated newborn infants. Arch Dis Child Fetal Neonatal Ed. 1995;73(1):F22–F6.
  • Wood CM, Rushforth JA, Hartley R, et al. Randomised double blind trial of morphine versus diamorphine for sedation of preterm neonates. Arch Dis Child Fetal Neonatal Ed. 1998;79(1):F34–F9.
  • Anand KJ, Barton BA, McIntosh N, et al. Analgesia and sedation in preterm neonates who require ventilatory support: results from the NOPAIN trial. Neonatal outcome and prolonged analgesia in neonates. Arch Pediatr Adolesc Med. 1999;153(4):331–338.
  • Lynn AM, Nespeca MK, Bratton SL, et al. Intravenous morphine in postoperative infants: intermittent bolus dosing versus targeted continuous infusions. Pain. 2000;88(1):89–95.
  • Anand KJ, Hall RW, Desai N, et al. Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial. Lancet. 2004;363(9422):1673–1682.
  • Carbajal R, Lenclen R, Jugie M, et al. Morphine does not provide adequate analgesia for acute procedural pain among preterm neonates. Pediatrics. 2005;115(6):1494–1500.
  • Taddio A, Lee C, Yip A, et al. Intravenous morphine and topical tetracaine for treatment of pain in [corrected] neonates undergoing central line placement. Jama. 2006;295(7):793–800.
  • Howard CR, Howard FM, Weitzman ML. Acetaminophen analgesia in neonatal circumcision: the effect on pain. Pediatrics. 1994;93(4):641–646.
  • Shah V, Taddio A, Ohlsson A. Randomised controlled trial of paracetamol for heel prick pain in neonates. Arch Dis Child Fetal Neonatal Ed. 1998;79(3):F209–F11.
  • Van Lingen RA, Quak CM, Deinum HT, et al. Effects of rectally administered paracetamol on infants delivered by vacuum extraction. Eur J Obstet Gynecol Reprod Biol. 2001;94(1):73–78.
  • Badiee Z, Torcan N. Effects of high dose orally administered paracetamol for heel prick pain in premature infants. Saudi Med J. 2009;30(11):1450–1453.
  • Manjunatha, C.M., Ibhanesebhor, S. E., Rennix, C, et al. Pain control during retinopathy of prematurity screening: double-blind, randomised, placebo-controlled study. Infant. 2009;5(5):155–158.
  • Tinner EM, Hoesli I, Jost K, et al. Rectal paracetamol in newborn infants after assisted vaginal delivery may increase pain response. J Pediatr. 2013;162(1):62–66.
  • Seifi F, Peirovifar A, Gharehbaghi MM. Caomparing the efficacy of oral sucrose and acetaminophen in pain relief for ophtalmologic screening of retinopathy of prematurity. Am J Med Sci Med. 2013;1(2):24–27.
  • Bhat R, Abu-Harb M, Chari G, et al. Morphine metabolism in acutely ill preterm newborn infants. J Pediatr. 1992;120(5):795–799.
  • Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology–drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349(12):1157–1167.
  • Coffman BL, Rios GR, King CD, et al. Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos. 1997;25(1):1–4.
  • Lynn A, Nespeca MK, Bratton SL, et al. Clearance of morphine in postoperative infants during intravenous infusion: the influence of age and surgery. Anesth Analg. 1998;86(5):958–963.
  • Bouwmeester NJ, Anderson BJ, Tibboel D, et al. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. Br J Anaesth. 2004;92(2):208–217.
  • Bouwmeester NJ, Hop WCJ, Van Dijk M, et al. Postoperative pain in the neonate: age-related differences in morphine requirements and metabolism. Intensive Care Med. 2003;29(11):2009–2015.
  • Wang C, Sadhavisvam S, Krekels EHJ, et al. Developmental changes in morphine clearance across the entire paediatric age range are best described by a bodyweight-dependent exponent model. Clin Drug Investig. 2013;33(7):523–534.
  • Meesters NJ, Van Dijk M, Knibbe CAJ, et al. Infants operated on for necrotizing enterocolitis: towards evidence-based pain guidelines. Neonatology. 2016;110(3):190–197.
  • Allegaert K, Vanhaesebrouck S, Verbesselt R, et al. In vivo glucuronidation activity of drugs in neonates: extensive interindividual variability despite their young age. Ther Drug Monit. 2009;31(4):411–415.
  • Altamimi MI, Choonara I, Sammons H. Inter-individual variation in morphine clearance in children. Eur J Clin Pharmacol. 2015;71(6):649–655.
  • Holford NH, Ma SC, Anderson BJ. Prediction of morphine dose in humans. Paediatr Anaesth. 2012;22(3):209–222.
  • Pokorna P, Wildschut ED, Vobruba V, et al. The impact of hypothermia on the pharmacokinetics of drugs used in neonates and young infants. Curr Pharm Des. 2015;21(39):5705–5724.
  • Wildschut, E.D., van Saet, A., Pokorna, P, et al. The impact of extracorporeal life support and hypothermia on drug disposition in critically ill infants and children. Pediatr Clin North Am. 2012;59(5):1183–1204.
  • Darbari, D.S., van Schaik, R. H., Capparelli, E. V, et al. UGT2B7 promoter variant −840G>A contributes to the variability in hepatic clearance of morphine in patients with sickle cell disease. Am J Hematol. 2008;83(3):200–202.
  • Mooij, M.G., Nies, A. T., Knibbe, C. A, et al. Development of human membrane transporters: drug disposition and pharmacogenetics. Clin Pharmacokinet. 2015;55(5):507–524.
  • Venkatasubramanian, R., R., Fukuda, T., Niu, et al. ABCC3 and OCT1 genotypes influence pharmacokinetics of morphine in children. Pharmacogenomics. 2014;15(10):1297–1309.
  • Dale O, Thoner J, Nilsen T, et al. Serum and cerebrospinal fluid morphine pharmacokinetics after single doses of intravenous and intramuscular morphine after hip replacement surgery. Eur J Clin Pharmacol. 2007;63(9):837–842.
  • Van Dongen RT, Crul BJ, Koopman-Kimenai PM, et al. Morphine and morphine-glucuronide concentrations in plasma and CSF during long-term administration of oral morphine. Br J Clin Pharmacol. 1994;38(3):271–273.
  • Hain RD, Hardcastle A, Pinkerton CR, et al. Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children. Br J Clin Pharmacol. 1999;48(1):37–42.
  • Dahan A, Lotsch J. Morphine is not a prodrug. Br J Anaesth. 2015;114(6):1005–1006.
  • Klimas R, Mikus G. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide. Br J Anaesth. 2014;113(6):935–944.
  • Martini C, Olofsen E, Yassen A, et al. Pharmacokinetic-pharmacodynamic modeling in acute and chronic pain: an overview of the recent literature. Expert Rev Clin Pharmacol. 2011;4(6):719–728.
  • Ahlers SJGM, Välitalo PAJ, Peeters MYM, et al. Morphine glucuronidation and elimination in intensive care patients: a comparison with healthy volunteers. Anesth Analg. 2015;121(5):1261–1273.
  • Valkenburg AJ, Calvier EAM, Van Dijk M, et al. Pharmacodynamics and pharmacokinetics of morphine after cardiac surgery in children with and without down syndrome. Pediatr Crit Care Med. 2016;17:930–938. Accepted for publication.
  • Lam J, Baello S, Iqbal M, et al. The ontogeny of P-glycoprotein in the developing human blood-brain barrier: implication for opioid toxicity in neonates. Pediatr Res. 2015;78(4):417–421.
  • Bengtsson J, Ederoth P, Ley D, et al. The influence of age on the distribution of morphine and morphine-3-glucuronide across the blood-brain barrier in sheep. Br J Pharmacol. 2009;157(6):1085–1096.
  • Auguy-Valette A, Cros J, Gouarderes C, et al. Morphine analgesia and cerebral opiate receptors: a developmental study. Br J Pharmacol. 1978;63(2):303–308.
  • Rai A, Bhalla S, Rebello SS, et al. Disposition of morphine in plasma and cerebrospinal fluid varies during neonatal development in pigs. J Pharm Pharmacol. 2005;57(8):981–986.
  • Saunders NR, Habgood MD, Møllgård K, et al. The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system? F1000Res. 2016;5. pii: F1000 Faculty Rev-313.
  • Kart T, Christrup LL, Rasmussen M. Recommended use of morphine in neonates, infants and children based on a literature review: part 2–clinical use. Paediatr Anaesth. 1997;7(2):93–101.
  • Anderson BJ, Van Den Anker J. Why is there no morphine concentration-response curve for acute pain? Paediatr Anaesth. 2014;24(3):233–238.
  • Sverrisdóttir E, Lund TM, Olesen AE, et al. A review of morphine and morphine-6-glucuronide’s pharmacokinetic-pharmacodynamic relationships in experimental and clinical pain. Eur J Pharm Sci. 2015;74:45–62.
  • Nandi R, Fitzgerald M. Opioid analgesia in the newborn. Eur J Pain. 2005;9(2):105–108.
  • Matic M, Simons SHP, Van Lingen RA, et al. Rescue morphine in mechanically ventilated newborns associated with combined OPRM1 and COMT genotype. Pharmacogenomics. 2014;15(10):1287–1295.
  • Wachman EM, Hayes MJ, Brown MS, et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. Jama. 2013;309(17):1821–1827.
  • Kowarik MC, Einhäuser J, Jochim B, et al. Impact of the COMT Val(108/158)met polymorphism on the mu-opioid receptor system in the human brain: mu-opioid receptor, met-enkephalin and beta-endorphin expression. Neurosci Lett. 2012;506(2):214–219.
  • Ostapowicz G, Lee WM. Acute hepatic failure: a Western perspective. J Gastroenterol Hepatol. 2000;15(5):480–488.
  • Squires RH Jr., Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148(5):652–658.
  • Ghanem CI, Pérez MJ, Manautou JE, et al. Acetaminophen from liver to brain: new insights into drug pharmacological action and toxicity. Pharmacol Res. 2016;109:119–131.
  • Van Der Marel CD, Anderson BJ, Van Lingen RA, et al. Paracetamol and metabolite pharmacokinetics in infants. Eur J Clin Pharmacol. 2003;59(3):243–251.
  • Zuppa AF, Hammer GB, Barrett JS, et al. Safety and population pharmacokinetic analysis of intravenous acetaminophen in neonates, infants, children, and adolescents with pain or fever. J Pediatr Pharmacol Ther. 2011;16(4):246–261.
  • Cook SF, Roberts JK, Samiee-Zafarghandy S, et al. Population pharmacokinetics of intravenous paracetamol (acetaminophen) in preterm and term neonates: model development and external evaluation. Clin Pharmacokinet. 2016;55(1):107–119.
  • Johnsrud EK, Koukouritaki SB, Divakaran K, et al. Human hepatic CYP2E1 expression during development. J Pharmacol Exp Ther. 2003;307(1):402–407.
  • Allegaert K, Rayyan M, De Rijdt T, et al. Hepatic tolerance of repeated intravenous paracetamol administration in neonates. Paediatr Anaesth. 2008;18(5):388–392.
  • Pacifici GM, Allegaert K. Clinical pharmacology of paracetamol in neonates: a review. Curr Ther Res Clin Exp. 2015;77:24–30.
  • Allegaert K, Van Der Marel CD, Debeer A, et al. Pharmacokinetics of single dose intravenous propacetamol in neonates: effect of gestational age. Arch Dis Child Fetal Neonatal Ed. 2004;89(1):F25–F8.
  • Allegaert K, Anderson BJ, Naulaers G, et al. Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm neonates. Eur J Clin Pharmacol. 2004;60(3):191–197.
  • Anderson BJ, Pons G, Autret-Leca E, et al. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis. Paediatr Anaesth. 2005;15(4):282–292.
  • Prins SA, Van Dijk M, Van Leeuwen P, et al. Pharmacokinetics and analgesic effects of intravenous propacetamol vs rectal paracetamol in children after major craniofacial surgery. Paediatr Anaesth. 2008;18(7):582–592.
  • Mooij MG, Van Duijn E, Knibbe CAJ, et al. Pediatric microdose study of [(14)C]paracetamol to study drug metabolism using accelerated mass spectrometry: proof of concept. Clin Pharmacokinet. 2014;53(11):1045–1051.
  • Allegaert K, Palmer GM, Anderson BJ. The pharmacokinetics of intravenous paracetamol in neonates: size matters most. Arch Dis Child. 2011;96(6):575–580.
  • Weber FD, Schmidt H, Pfister M, et al. Pharmacometric approach to characterize key metabolites of acetaminophen in preterm and term neonates., in PAGE meeting. Hersonissos, Greece; 2015.
  • Krasniak AE, Knipp GT, Svensson CK, et al. Pharmacogenomics of acetaminophen in pediatric populations: a moving target. Front Genet. 2014;5:314.
  • Krekels EH, Johnson TN, Den Hoedt SM, et al. from pediatric covariate model to semiphysiological function for maturation: part ii-sensitivity to physiological and physicochemical properties. CPT Pharmacometrics Syst Pharmacol. 2012;1:e10.
  • Anderson BJ. Paracetamol (acetaminophen): mechanisms of action. Paediatr Anaesth. 2008;18(10):915–921.
  • Anderson BJ, Holford NH, Woollard GA, et al. Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children. Br J Clin Pharmacol. 1998;46(3):237–243.
  • Van Der Marel CD, Anderson BJ, Pluim MAL, et al. Acetaminophen in cerebrospinal fluid in children. Eur J Clin Pharmacol. 2003;59(4):297–302.
  • Gibb IA, Anderson BJ. Paracetamol (acetaminophen) pharmacodynamics: interpreting the plasma concentration. Arch Dis Child. 2008;93(3):241–247.
  • Anderson B, Kanagasundarum S, Woollard G. Analgesic efficacy of paracetamol in children using tonsillectomy as a pain model. Anaesth Intensive Care. 1996;24(6):669–673.
  • Korpela R, Korvenoja P, Meretoja OA. Morphine-sparing effect of acetaminophen in pediatric day-case surgery. Anesthesiology. 1999;91(2):442–447.
  • Birmingham PK, Tobin MJ, Henthorn TK, et al. Twenty-four-hour pharmacokinetics of rectal acetaminophen in children: an old drug with new recommendations. Anesthesiology. 1997;87(2):244–252.
  • Nour C, Ratsiu J, Singh N, et al. Analgesic effectiveness of acetaminophen for primary cleft palate repair in young children: a randomized placebo controlled trial. Paediatr Anaesth. 2014;24(6):574–581.
  • Hong JY, Kim WO, Koo BN, et al. Fentanyl-sparing effect of acetaminophen as a mixture of fentanyl in intravenous parent-/nurse-controlled analgesia after pediatric ureteroneocystostomy. Anesthesiology. 2010;113(3):672–677.
  • Wong I, St John-Green C, Walker SM. Opioid-sparing effects of perioperative paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs) in children. Paediatr Anaesth. 2013;23(6):475–495.
  • Steinhorn R, McPherson C, Anderson PJ, et al. Neonatal morphine exposure in very preterm infants-cerebral development and outcomes. J Pediatr. 2015;166(5):1200–1207. e4.
  • Van Den Bosch GE, White T, El Marroun H, et al. Prematurity, opioid exposure and neonatal pain: do they affect the developing brain? Neonatology. 2015;108(1):8–15.
  • Rappaport BA, Suresh S, Hertz S, et al. Anesthetic neurotoxicity–clinical implications of animal models. N Engl J Med. 2015;372(9):796–797.
  • Zwicker JG, Miller SP, Grunau RE, et al. Smaller cerebellar growth and poorer neurodevelopmental outcomes in very preterm infants exposed to neonatal morphine. J Pediatr. 2016;172:81–87. e2.
  • De Graaf J, Van Lingen RA, Simons SHP, et al. Long-term effects of routine morphine infusion in mechanically ventilated neonates on children’s functioning: five-year follow-up of a randomized controlled trial. Pain. 2011;152(6):1391–1397.
  • De Graaf J, Van Lingen RA, Valkenburg AJ, et al. Does neonatal morphine use affect neuropsychological outcomes at 8 to 9 years of age? Pain. 2013;154(3):449–458.
  • Carbajal R, Eriksson M, Courtois E, et al. Sedation and analgesia practices in neonatal intensive care units (EUROPAIN): results from a prospective cohort study. Lancet Respir Med. 2015;3(10):796–812.
  • Van Den Anker JN, Van Dijk M, Tibboel D. Impaired neurodevelopmental outcomes in very preterm infants: much too easy to blame it just on morphine! J Pediatr. 2016;172:7–8.
  • Schuurmans J, Benders M, Lemmers P, et al. Neonatal morphine in extremely and very preterm neonates: its effect on the developing brain - a review. J Matern Fetal Neonatal Med. 2015;28(2):222–228.
  • Farooqi A, Adamsson M, Serenius F, et al. Executive functioning and learning skills of adolescent children born at fewer than 26 weeks of gestation. PLoS One. 2016;11(3):e0151819.
  • Magnus MC, Karlstad Ø, Håberg SE, et al. Prenatal and infant paracetamol exposure and development of asthma: the Norwegian mother and child cohort study. Int J Epidemiol. 2016;45(2):512–522.
  • Cheelo M, Lodge CJ, Dharmage SC, et al. Paracetamol exposure in pregnancy and early childhood and development of childhood asthma: a systematic review and meta-analysis. Arch Dis Child. 2015;100(1):81–89.
  • Sordillo JE, Scirica CV, Rifas-Shiman SL, et al. Prenatal and infant exposure to acetaminophen and ibuprofen and the risk for wheeze and asthma in children. J Allergy Clin Immunol. 2015;135(2):441–448.
  • Migliore E, Zugna D, Galassi C, et al. Prenatal paracetamol exposure and wheezing in childhood: causation or confounding? PLoS One. 2015;10(8):e0135775.
  • Weatherall M, Ioannides S, Braithwaite I, et al. The association between paracetamol use and asthma: causation or coincidence? Clin Exp Allergy. 2015;45(1):108–113.
  • Riley J, Braithwaite I, Shirtcliffe P, et al. Randomized controlled trial of asthma risk with paracetamol use in infancy–a feasibility study. Clin Exp Allergy. 2015;45(2):448–456.
  • Kang SH, Jung Y-H, Kim HY, et al. Effect of paracetamol use on the modification of the development of asthma by reactive oxygen species genes. Ann Allergy Asthma Immunol. 2013;110(5):364–369. e1.
  • Lee SH, Kang M-J, Yu H-S, et al. Association between recent acetaminophen use and asthma: modification by polymorphism at TLR4. J Korean Med Sci. 2014;29(5):662–668.
  • Ranger M, Zwicker JG, Chau CMY, et al. Neonatal pain and infection relate to smaller cerebellum in very preterm children at school age. J Pediatr. 2015;167(2):292–298. e1.
  • Brummelte S, Grunau RE, Chau V, et al. Procedural pain and brain development in premature newborns. Ann Neurol. 2012;71(3):385–396.
  • Grunau RE, Tu MT, Whitfield MF, et al. Cortisol, behavior, and heart rate reactivity to immunization pain at 4 months corrected age in infants born very preterm. Clin J Pain. 2010;26(8):698–704.
  • Holsti L, Zwicker JG, Grunau RE, et al. Entitled ‘prematurity, opioid exposure and neonatal pain: do they affect the developing brain’: the impact of subtle messaging. Neonatology. 2016;109(2):120–121.
  • Van Den Bosch GE, White T, Tibboel D, et al. Is the glass half full or half empty? Neonatology. 2016;109(2):122–123.
  • Carbajal R, Rousset A, Danan C, et al. Epidemiology and treatment of painful procedures in neonates in intensive care units. Jama. 2008;300(1):60–70.
  • Simons SH, Van Dijk M, Anand KS, et al. Do we still hurt newborn babies? A prospective study of procedural pain and analgesia in neonates. Arch Pediatr Adolesc Med. 2003;157(11):1058–1064.
  • Roofthooft DW, Simons SHP, Anand KJS, et al. Eight years later, are we still hurting newborn infants? Neonatology. 2014;105(3):218–226.
  • Slater R, Cantarella A, Gallella S, et al. Cortical pain responses in human infants. J Neurosci. 2006;26(14):3662–3666.
  • Association of Paediatric Anaesthetists of Great, B. and Ireland. Good practice in postoperative and procedural pain management, 2nd edition. Paediatr Anaesth. 2012;22(Suppl 1):1–79.
  • Knosgaard KR, Foster DJR, Kreilgaard M, et al. Pharmacokinetic models of morphine and its metabolites in neonates: systematic comparisons of models from the literature, and development of a new meta-model. Eur J Pharm Sci. 2016;92:117–130.
  • Anand KJ, Anderson BJ, Holford NHG, et al. Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial. Br J Anaesth. 2008;101(5):680–689.
  • Allegaert K, Anderson B, Simons S, et al. Paracetamol to induce ductus arteriosus closure: is it valid? Arch Dis Child. 2013;98(6):462–466.
  • Hartley C, Goksan S, Poorun R, et al. The relationship between nociceptive brain activity, spinal reflex withdrawal and behaviour in newborn infants. Sci Rep. 2015;5:12519.
  • Valkenburg AJ, Van Den Bosch GE, De Graaf J, et al. Long-term effects of neonatal morphine infusion on pain sensitivity: follow-up of a randomized controlled trial. J Pain. 2015;16(9):926–933.
  • Van Den Bosch GE, IJsselstijn H, Van Der Lugt A, et al. Neuroimaging, pain sensitivity, and neuropsychological functioning in school-age neonatal extracorporeal membrane oxygenation survivors exposed to opioids and sedatives. Pediatr Crit Care Med. 2015;16(7):652–662.
  • Salomons TV, Iannetti GD, Liang M, et al. The “pain matrix” in pain-free individuals. JAMA Neurol. 2016;73(6):755–756.
  • Krekels EH, Tibboel D, Knibbe CA. Pediatric pharmacology: current efforts and future goals to improve clinical practice. Expert Opin Drug Metab Toxicol. 2015;11(11):1679–1682.
  • Clark RH, Bloom BT, Spitzer AR, et al. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics. 2006;117(6):1979–1987.
  • Kumar P, Walker JK, Hurt KM, et al. Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications. J Pediatr. 2008;152(3):412–415.
  • Pacifici GM. Clinical pharmacology of fentanyl in preterm infants. A review. Pediatr Neonatol. 2015;56(3):143–148.
  • Orsini AJ, Leef KH, Costarino A, et al. Routine use of fentanyl infusions for pain and stress reduction in infants with respiratory distress syndrome. J Pediatr. 1996;129(1):140–145.
  • Guinsburg R, Kopelman BI, Anand KJ, et al. Physiological, hormonal, and behavioral responses to a single fentanyl dose in intubated and ventilated preterm neonates. J Pediatr. 1998;132(6):954–959.
  • Ancora G, Lago P, Garetti E, et al. Efficacy and safety of continuous infusion of fentanyl for pain control in preterm newborns on mechanical ventilation. J Pediatr. 2013;163(3):645–651. e1.
  • England A, Wade K, Smith PB, et al. Optimizing operational efficiencies in early phase trials: the pediatric trials network experience. Contemp Clin Trials. 2016;47:376–382.
  • Lago P, Tiozzo C, Boccuzzo G, et al. Remifentanil for percutaneous intravenous central catheter placement in preterm infant: a randomized controlled trial. Paediatr Anaesth. 2008;18(8):736–744.
  • Choong K, AlFaleh K, Doucette J, et al. Remifentanil for endotracheal intubation in neonates: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2010;95(2):F80–F4.
  • Welzing L, Oberthuer A, Junghaenel S, et al. Remifentanil/midazolam versus fentanyl/midazolam for analgesia and sedation of mechanically ventilated neonates and young infants: a randomized controlled trial. Intensive Care Med. 2012;38(6):1017–1024.
  • Van Den Anker JN. Treating pain in newborn infants: navigating between scylla and charybdis. J Pediatr. 2013;163(3):618–619.